SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
SEC Accession No. 0001493152-21-022429
Filing Date
2021-09-10
Accepted
2021-09-10 16:56:41
Documents
3

Document Format Files

Seq Description Document Type Size
1 forms-3a.htm S-3/A 485731
2 ex23-1.htm EX-23.1 5052
3 logo_001.jpg GRAPHIC 14609
  Complete submission text file 0001493152-21-022429.txt   512280
Mailing Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010
Business Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010 (212) 994-8200
Protagenic Therapeutics, Inc.\new (Filer) CIK: 0001022899 (see all company filings)

IRS No.: 061390025 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3/A | Act: 33 | File No.: 333-258825 | Film No.: 211247639
SIC: 7389 Services-Business Services, NEC